Ultralife Statistics
Total Valuation
Ultralife has a market cap or net worth of $73.35 million. The enterprise value is $124.89 million.
| Market Cap | 73.35M |
| Enterprise Value | 124.89M |
Important Dates
The next estimated earnings date is Thursday, April 24, 2025, before market open.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ultralife has 16.63 million shares outstanding. The number of shares has increased by 3.33% in one year.
| Current Share Class | 16.63M |
| Shares Outstanding | 16.63M |
| Shares Change (YoY) | +3.33% |
| Shares Change (QoQ) | -0.66% |
| Owned by Insiders (%) | 35.99% |
| Owned by Institutions (%) | 41.28% |
| Float | 10.65M |
Valuation Ratios
The trailing PE ratio is 11.61 and the forward PE ratio is 4.79.
| PE Ratio | 11.61 |
| Forward PE | 4.79 |
| PS Ratio | 0.44 |
| Forward PS | 0.33 |
| PB Ratio | 0.55 |
| P/TBV Ratio | 1.14 |
| P/FCF Ratio | 4.99 |
| P/OCF Ratio | 4.41 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.84, with an EV/FCF ratio of 8.49.
| EV / Earnings | 19.79 |
| EV / Sales | 0.76 |
| EV / EBITDA | 8.84 |
| EV / EBIT | 12.53 |
| EV / FCF | 8.49 |
Financial Position
The company has a current ratio of 3.32, with a Debt / Equity ratio of 0.44.
| Current Ratio | 3.32 |
| Quick Ratio | 1.24 |
| Debt / Equity | 0.44 |
| Debt / EBITDA | 3.81 |
| Debt / FCF | 3.97 |
| Interest Coverage | 5.14 |
Financial Efficiency
Return on equity (ROE) is 4.94% and return on invested capital (ROIC) is 3.59%.
| Return on Equity (ROE) | 4.94% |
| Return on Assets (ROA) | 3.12% |
| Return on Invested Capital (ROIC) | 3.59% |
| Return on Capital Employed (ROCE) | 5.21% |
| Revenue Per Employee | $245,091 |
| Profits Per Employee | $9,407 |
| Employee Count | 671 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 2.61 |
Taxes
In the past 12 months, Ultralife has paid $1.89 million in taxes.
| Income Tax | 1.89M |
| Effective Tax Rate | 22.79% |
Stock Price Statistics
The stock price has decreased by -50.78% in the last 52 weeks. The beta is 0.96, so Ultralife's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | -50.78% |
| 50-Day Moving Average | 5.92 |
| 200-Day Moving Average | 8.28 |
| Relative Strength Index (RSI) | 33.30 |
| Average Volume (20 Days) | 72,758 |
Short Selling Information
The latest short interest is 316,904, so 1.91% of the outstanding shares have been sold short.
| Short Interest | 316,904 |
| Short Previous Month | 288,810 |
| Short % of Shares Out | 1.91% |
| Short % of Float | 2.98% |
| Short Ratio (days to cover) | 6.10 |
Income Statement
In the last 12 months, Ultralife had revenue of $164.46 million and earned $6.31 million in profits. Earnings per share was $0.38.
| Revenue | 164.46M |
| Gross Profit | 42.31M |
| Operating Income | 9.97M |
| Pretax Income | 12.33M |
| Net Income | 6.31M |
| EBITDA | 14.12M |
| EBIT | 9.97M |
| Earnings Per Share (EPS) | $0.38 |
Balance Sheet
The company has $6.85 million in cash and $58.39 million in debt, giving a net cash position of -$51.53 million or -$3.10 per share.
| Cash & Cash Equivalents | 6.85M |
| Total Debt | 58.39M |
| Net Cash | -51.53M |
| Net Cash Per Share | -$3.10 |
| Equity (Book Value) | 134.19M |
| Book Value Per Share | 8.06 |
| Working Capital | 67.87M |
Cash Flow
In the last 12 months, operating cash flow was $16.64 million and capital expenditures -$1.93 million, giving a free cash flow of $14.70 million.
| Operating Cash Flow | 16.64M |
| Capital Expenditures | -1.93M |
| Free Cash Flow | 14.70M |
| FCF Per Share | $0.88 |
Margins
Gross margin is 25.73%, with operating and profit margins of 6.06% and 3.84%.
| Gross Margin | 25.73% |
| Operating Margin | 6.06% |
| Pretax Margin | 5.05% |
| Profit Margin | 3.84% |
| EBITDA Margin | 8.59% |
| EBIT Margin | 6.06% |
| FCF Margin | 8.94% |
Dividends & Yields
Ultralife does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.33% |
| Shareholder Yield | -3.33% |
| Earnings Yield | 8.61% |
| FCF Yield | 20.05% |
Analyst Forecast
The average price target for Ultralife is $14.00, which is 217.46% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.00 |
| Price Target Difference | 217.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ultralife has an Altman Z-Score of 2.12 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.12 |
| Piotroski F-Score | 5 |